Proactive - Interviews for investors

King Ridge Capital Inc CEO Rick Pagnani talked with Proactive's Stephen Gunnion about the KRC Cat Bond UCITS ETF (CATB), explaining how catastrophe bonds work and why they can play a valuable role in diversified portfolios. Pagnani outlined that cat bonds are insurance-linked securities that allow insurers to transfer risk to capital markets. These instruments are “fully collateralised and decoupl...

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to discuss the company’s newly signed Research and Development License Agreement (RDLA) with Rhizome Food and Farming, a North American food company led by renowned chef Dan Barber, a recipient of multiple Michelin stars. Charleton explained that the agreement builds on prior engagement involving Row 7, which, through its c...

Coiled Therapeutics (AIM:COIL) executive chair Dr Sotirios Stergiopoulos and CEO Sridhar Vempati talked with Proactive's Stephen Gunnion about promising clinical results for its lead oncology candidate AO-252. The discussion highlighted a significant improvement in clinical outcomes, with the company reporting an increase in clinical benefit rate from 40% to 80% following a shift to twice-daily do...

ICG Silver and Gold CEO Steven Sirbovan joined Steve Darling from Proactive to announce that the company has completed the staking and consolidation of eight newly available mineral claims, covering approximately 85 acres within the highly prospective Tuscarora District in Nevada. The newly acquired claims were identified through ongoing technical evaluation, incorporating recently completed geoph...

MedPal AI CEO Jason Drummond joined Steve Darling from Proactive to talk about the rapid growth of the company’s AI-powered healthcare platform and its vision to transform access to primary care. Drummond explained how MedPal AI aggregates data from connected health devices such as Apple Watch, Fitbit, and Oura Ring into a single platform, allowing users to gain real-time health insights. He highl...

Solvonis Therapeutics PLC (LSE:SVNS) CEO Anthony Tennyson talked with Proactive's Stephen Gunnion about the company securing two US patents that significantly strengthen its PTSD treatment program. Tennyson explained that the patents cover two distinct chemical series, reinforcing the company’s intellectual property position and demonstrating that Solvonis is building “a novel chemistry platform a...

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about encouraging results from the SLAB (Sarcopenia and Longevity in Aged Beagles) trial, highlighting sustained efficacy and safety following treatment. Leire explained that one of the most significant findings is the durability of the therapy’s effects. Even three months after stopp...

Quantum Blockchain Technologies PLC (AIM:QBT, FRA:BYA1) CEO Francesco Gardin talked with Proactive's Stephen Gunnion about progress in the company’s AI Oracle development and how it could significantly reduce deployment timelines for Bitcoin mining optimisation. Gardin explained that the company has introduced a mining development kit (MDK), allowing its AI Oracle to operate via a server connected...

Sunda Energy PLC (AIM:SNDA) CEO Andy Butler talked with Proactive's Stephen Gunnion about the company’s latest strategic developments, including a transformational acquisition in New Zealand, progress across its international portfolio, and a strengthened funding position. Butler outlined how the acquisition marks a major step forward, positioning Sunda Energy as a production-focused company with...

Quantum Helium Limited CEO Howard Mclaughlin joined Steve Darling from Proactive to announce that the company has received approval from the Bureau of Indian Affairs to assume operatorship of the Sagebrush Project in Colorado, marking a key milestone in its development strategy. McLaughlin explained that Quantum holds prospective helium resources of more than 1 billion cubic feet across its Sagebr...

Bit Digital CEO Sam Tabar joined Steve Darling from Proactive to discuss the company’s 2025 financial results, its strategic shift away from Bitcoin mining, and its growing focus on Ethereum staking and AI infrastructure. The company reported approximately $115 million in revenue for 2025, reflecting a deliberate transformation of its business model. Tabar explained that Bit Digital Inc has been r...

BlockchaAIn Digital Infrastructure, COO Eyal Rozen joined Steve Darling from Proactive to discuss the company’s strategic shift toward AI-focused data centers and its recent listing on the NYSE American. Rozen explained that the company, originally founded in 2022 with a focus on Bitcoin mining, has rapidly evolved to meet surging demand for AI infrastructure. Recognizing early that AI workloads w...

Immunic Inc (NASDAQ:IMUX, FRA:10VA) chief operating officer Jason Tardio talked with Proactive's Stephen Gunnion about the importance of science-led innovation in tackling neurological diseases, particularly multiple sclerosis, on World Health Day 2026. Tardio highlighted that the biotech industry is fundamentally grounded in scientific research and data, noting that “everything we do is rooted in...

Gelion PLC (AIM:GELN) chief technology officer Louis Adriaenssens joined Proactive's Stephen Gunnion to explain why the company's expanded collaboration with TDK Corporation could be a defining moment for its NES cathode technology. Adriaenssens revealed how Gelion has successfully transferred its technology into a pouch cell format, a critical step on the road to commercialisation, and why its ca...

One Bullion CEO Adam Berk joined Steve Darling from Proactive to discuss the company’s rapid growth following its recent public listing and its expanding gold exploration footprint across Africa. Berk explained that One Bullion Ltd has quickly established a strong presence, controlling more than 5,000 square kilometres across three key projects: Vumba, Maitengwe, and Kraaipan. He emphasized the st...

Medicus Pharma Chief Medical Officer Dr Faisal Mehmud joined Steve Darling from Proactive to announce that the company has submitted an optimized Phase 2 clinical study design to the U.S. Food and Drug Administration for Teverelix. The therapy is being developed to help prevent recurrent acute urinary retention (AUR) in men with benign prostatic hyperplasia (BPH) under the company’s existing open...

American Rare Earths CEO Mark Wall joined Steve Darling from Proactive to announce rapid progress on the company’s pilot plant program aimed at producing pre-production rare earth concentrate from Halleck Creek ore. As part of this advancement, the company has engaged Jaye T. Pickarts, P.E. to lead the pilot plant process, bringing extensive U.S.-based rare earth and project development expertise...

Valereum PLC (AQSE:VLRM, FRA:6TJ, OTCQB:VLRMF) CEO Gary Cottle talked with Proactive about the launch of VGOLD, a new product aiming to differentiate itself in the growing tokenised gold market by offering yield alongside digital gold exposure. Cottle explained that VGOLD stands out as “probably the only gold token that will pay a yield or a coupon,” adding that investors who stake tokens for long...

Abingdon Health PLC (AIM:ABDX) executive chairman Dr Chris Hand talked with Proactive's Stephen Gunnion about the company’s strong first-half performance, recent contract wins and growth outlook in the diagnostics market. Hand explained that Abingdon Health operates as a contract development and manufacturing organisation specialising in lateral flow and rapid diagnostic testing, now offering a fu...

RC Fornax PLC (AIM:RCFX) finance director Rob Shepherd talked with Proactive's Stephen Gunnion about the company’s latest trading update, highlighting strong sales momentum, growing order visibility, and a positive outlook driven by both internal improvements and favourable market conditions. Shepherd explained that the company has already surpassed its previous full-year revenue within just seven...

Ariana Resources PLC (AIM:AAU, ASX:AA2, FRA:4A6) managing director Kerim Sener talked with Proactive's Stephen Gunnion about the company’s 2025 results, funding position, and progress across its key gold projects, including Dokwe and Tavşan. Sener outlined a “very pleasing end to the year,” highlighting a stronger cash position following an investment from Xinhai, leaving the company with approxim...

Quantum Blockchain Technologies PLC (AIM:QBT, FRA:BYA1) CEO Francesco Gardin talked with Proactive's Stephen Gunnion about latest developments across the company’s US patent application process, AI software implementation, and ongoing hardware deployment. Gardin provided an update on the ASIC Ultraboost patent application in the United States, explaining that the company is actively engaging with...

Purepoint Uranium Group CEO Chris Frostad joined Steve Darling from Proactive to discuss the company’s latest uranium exploration progress at its Dorado project in northern Saskatchewan, as well as the broader process of making and advancing a discovery. Frostad explained that Purepoint Uranium Group operates in one of the world’s most prolific uranium regions, collaborating with major partners in...

American Resources Corp CFO Kirk Taylor joined Steve Darling from Proactive to announce a strategic collaboration with Mitsubishi Materials Corporation, a global leader in advanced materials and resource circulation. The partnership includes a strategic investment in ReElement Technologies, reinforcing confidence in its refining-first platform and its role in strengthening critical mineral supply...

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to report independent clinical validation of the company’s Phase 2 SkinJect® dataset by Dr. Babar Rao, principal investigator of the SKNJCT-003 study and a globally recognized leader in dermatology and skin cancer research. According to Dr. Rao’s independen...